VivoSim Labs
VIVS
115 hedge funds and large institutions have $76.7M invested in VivoSim Labs in 2017 Q1 according to their latest regulatory filings, with 10 funds opening new positions, 34 increasing their positions, 29 reducing their positions, and 16 closing their positions.
17% more repeat investments, than reductions
Existing positions increased: 34 | Existing positions reduced: 29
0% more ownership
Funds ownership: 0.1% → 0.1% (+0%)
6% less capital invested
Capital invested by funds: $81.4M → $76.7M (-$4.72M)
10% less funds holding
Funds holding: 128 → 115 (-13)
38% less first-time investments, than exits
New positions opened: 10 | Existing positions closed: 16
58% less call options, than puts
Call options by funds: $722K | Put options by funds: $1.71M
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
BlackRock
New York
|
+$24.9M |
| 2 |
Vanguard Group
Malvern,
Pennsylvania
|
+$1.1M |
| 3 |
UBS Group
Zurich,
Switzerland
|
+$1.01M |
| 4 |
Geode Capital Management
Boston,
Massachusetts
|
+$973K |
| 5 |
AIM
ARK Investment Management
St. Petersburg,
Florida
|
+$528K |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
Susquehanna International Group
Bala Cynwyd,
Pennsylvania
|
-$2.72M |
| 2 |
Norges Bank
Oslo,
Norway
|
-$1.03M |
| 3 |
D.E. Shaw & Co
New York
|
-$610K |
| 4 |
Citigroup
New York
|
-$232K |
| 5 |
QIM
Quantitative Investment Management
Charlottesville,
Virginia
|
-$231K |
VIVS Hedge Fund Activity: Q1 2017 in Review
115 of the 4,017 institutional investors tracked by Wall St. Rank reported a position in VivoSim Labs (VIVS) for Q1 2017, worth a combined $76.7M — down 5.8% from $81.4M a quarter earlier.
Sellers outnumbered buyers: 16 funds closed out of VIVS and 10 opened new positions — a net loss of 6 holders — while 29 trimmed existing stakes and 34 added.
The largest buyer was BlackRock, adding an estimated $24.9M. The largest seller was Susquehanna International Group, cutting an estimated $2.72M.
- 115 institutional investors held VivoSim Labs (VIVS) as of Q1 2017, down from 128 in Q4 2016.
- Funds reported $76.7M of VivoSim Labs stock for Q1 2017, down 5.8% quarter-over-quarter.
- 10 funds opened new VivoSim Labs positions in Q1 2017 and 16 closed out, a net change of -6 holders.
- The largest VivoSim Labs buyer in Q1 2017 was BlackRock, an estimated $24.9M added.
- The largest VivoSim Labs seller in Q1 2017 was Susquehanna International Group, an estimated $2.72M sold.
Based on aggregated 13F filings for Q1 2017.